CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza, and other viral infectious diseases.
CytoAgents has raised $2.3M in total funding. The most recent round was Grant. The last funding was announced in October 2025.
CytoAgents's investors include Innovation Works, National Institutes of Health, AlphaLab Health, Richard King Mellon Foundation, EQx Fund.
CytoAgents is headquartered in Pittsburgh, United States.
CytoAgents is a biotechnology company focused on the the treatment of COVID-19, Influenza, and other viral infectious diseases.
CytoAgents is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CytoAgents — Funding & Investors." VCBacked, October 1, 2025, https://www.vcbacked.co/company/cytoagents. Accessed September 2, 2026.
VCBacked. (2025). CytoAgents — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/cytoagents
{{cite web |title=CytoAgents — Funding & Investors |url=https://www.vcbacked.co/company/cytoagents |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated